Alpha Teknova, Inc. (TKNO)
TKNO Stock Price Chart
Explore Alpha Teknova, Inc. interactive price chart. Choose custom timeframes to analyze TKNO price movements and trends.
TKNO Company Profile
Discover essential business fundamentals and corporate details for Alpha Teknova, Inc. (TKNO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
25 Jun 2021
Employees
173.00
Website
https://www.teknova.comCEO
Stephen Gunstream
Description
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
TKNO Financial Timeline
Browse a chronological timeline of Alpha Teknova, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Nov 2025
Revenue estimate is $10.35M.
Earnings released on 7 Aug 2025
EPS came in at -$0.07 surpassing the estimated -$0.10 by +30.25%, while revenue for the quarter reached $10.29M , beating expectations by +3.95%.
Earnings released on 8 May 2025
EPS came in at -$0.09 surpassing the estimated -$0.11 by +18.18%, while revenue for the quarter reached $9.80M , missing expectations by -1.34%.
Earnings released on 4 Mar 2025
EPS came in at -$0.11 surpassing the estimated -$0.12 by +8.33%, while revenue for the quarter reached $9.27M , beating expectations by +5.63%.
Earnings released on 7 Nov 2024
EPS came in at -$0.15 falling short of the estimated -$0.11 by -36.36%, while revenue for the quarter reached $9.58M , beating expectations by +4.16%.
Earnings released on 13 Aug 2024
EPS came in at -$0.13 surpassing the estimated -$0.16 by +18.75%, while revenue for the quarter reached $9.61M , beating expectations by +1.63%.
Earnings released on 13 May 2024
EPS came in at -$0.20 surpassing the estimated -$0.24 by +16.67%, while revenue for the quarter reached $9.29M , beating expectations by +9.89%.
Earnings released on 11 Mar 2024
EPS came in at -$0.22 surpassing the estimated -$0.23 by +4.35%, while revenue for the quarter reached $7.87M , missing expectations by -5.58%.
Earnings released on 9 Nov 2023
EPS came in at -$0.34 falling short of the estimated -$0.28 by -21.43%, while revenue for the quarter reached $8.17M , missing expectations by -0.83%.
Earnings released on 10 Aug 2023
EPS came in at -$0.25 surpassing the estimated -$0.26 by +3.85%, while revenue for the quarter reached $11.53M , beating expectations by +18.76%.
Earnings released on 10 May 2023
EPS came in at -$0.31 falling short of the estimated -$0.30 by -3.33%, while revenue for the quarter reached $9.12M , beating expectations by +12.45%.
Earnings released on 15 Mar 2023
EPS came in at -$0.47 falling short of the estimated $0.34 by -238.24%, while revenue for the quarter reached $7.89M , beating expectations by +2.45%.
Earnings released on 9 Nov 2022
EPS came in at -$0.21 surpassing the estimated -$0.29 by +27.59%, while revenue for the quarter reached $10.69M , beating expectations by +21.22%.
Earnings released on 10 Aug 2022
EPS came in at -$0.22 surpassing the estimated -$0.25 by +12.00%, while revenue for the quarter reached $11.69M , beating expectations by +7.70%.
Earnings released on 11 May 2022
EPS came in at -$0.20 matching the estimated -$0.20, while revenue for the quarter reached $11.15M , beating expectations by +10.73%.
Earnings released on 15 Mar 2022
EPS came in at -$0.13 surpassing the estimated -$0.17 by +23.53%, while revenue for the quarter reached $10.11M , beating expectations by +19.87%.
Earnings released on 10 Nov 2021
EPS came in at -$0.12 matching the estimated -$0.12, while revenue for the quarter reached $9.39M , meeting expectations.
Earnings released on 11 Aug 2021
EPS came in at -$0.52 falling short of the estimated -$0.09 by -477.78%, while revenue for the quarter reached $8.31M , meeting expectations.
Earnings released on 25 Jun 2021
EPS came in at $0.03 , while revenue for the quarter reached $10.16M .
Earnings released on 31 Mar 2021
EPS came in at -$0.03 , while revenue for the quarter reached $9.08M .
Earnings released on 30 Sept 2020
EPS came in at $0.07 , while revenue for the quarter reached $8.98M .
TKNO Stock Performance
Access detailed TKNO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.